A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report.

ABSTRACT:

Background

Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has been evidence of thrombotic risk in patients with immune thrombocytopenia, but the mechanism is still inconclusive. Intravenous immunoglobulin infusion therapy is considered an efficient treatment; however, it still is associated with adverse events of fever, chills, and hypotension, as well as serious complications such as thrombosis. We report a case a patient with relapsed immune thrombocytopenia who developed ischemic stroke after an intravenous immunoglobulin infusion.

Case presentation

A 49-year-old Thai woman with relapsed/refractory immune thrombocytopenia came to our hospital with a large hematoma at the right buttock, and her platelet was decreased to 3 × 10⁹/L. She

SUBMITTER: Rungjirajittranon T 

PROVIDER: S-EPMC6348674 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature